Keytruda, the cancer drug used to treat the melanoma that had spread to former President Jimmy Carter’s brain, is already approved as a secondline cancer therapy, but a new study is showing it is effective as a firstline treatment. Dr. Natalie Azar tells TODAY that study participants on Keytruda were doing so well that doctors ended the trial early because it would be unethical not to give all the patients the drug.
» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY's Website: http://on.today.com/ReadTODAY
Find TODAY on Facebook: http://on.today.com/LikeTODAY
Follow TODAY on Twitter: http://on.today.com/FollowTODAY
Follow TODAY on Google+: http://on.today.com/PlusTODAY
Follow TODAY on Instagram: http://on.today.com/InstaTODAY
Follow TODAY on Pinterest: http://on.today.com/PinTODAY

Keytruda, Immunotherapy Drug That Aided Jimmy Carter’s Cancer, ‘A Huge Deal’ | TODAY